Lamotrigine Neuraxpharm

Lamotrigine, the active ingredient in Lamotrigine Neuraxpharm, is an antiepileptic presented as an oral tablet for oral use. It is prescribed for the treatment of focal seizures, generalized tonic‑clonic seizures, Lennox‑Gastaut syndrome, and as maintenance therapy in bipolar disorder in adult patients. It is approved for use in the European Union and is available by prescription only.

GNH USA supplies Lamotrigine Neuraxpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Lamotrigine is used to control seizure activity and stabilize mood in several neurological and psychiatric conditions.

- Focal seizures: reduces frequency and severity of partial onset seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Lennox‑Gastaut syndrome: decreases drop attacks and improves overall seizure control. - Bipolar disorder (maintenance therapy): maintains mood stability and reduces relapse risk.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient light‑headedness or imbalance. - Headache: mild to moderate intensity. - Nausea: occasional stomach upset. - Rash: skin irritation that may be pruritic. - Blurred vision: temporary visual disturbances. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions requiring immediate medical attention. - Blood dyscrasias: such as agranulocytosis or aplastic anemia. - Hepatic failure: signs of liver dysfunction. - Suicidal thoughts or behavior: new or worsening mood changes. - Severe hypersensitivity reactions: including anaphylaxis.

Before initiating therapy, clinicians should consider several safety measures.

- Rash monitoring: discontinue immediately if a widespread or severe rash develops. - Hepatic function: adjust dosing in patients with liver impairment. - Pregnancy: use only if the benefit outweighs risk; category C. - Blood counts: periodic monitoring for hematologic abnormalities. - Drug discontinuation: taper gradually to avoid seizure exacerbation. - Storage: Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Lamotrigine interacts with several medicines that can alter its plasma levels or increase toxicity.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine concentrations. - Carbamazepine: reduces lamotrigine levels, potentially decreasing efficacy. - Phenytoin: lowers lamotrigine exposure. - Oral contraceptives: decrease lamotrigine levels, may require dose adjustment. - Strong enzyme inducers (e.g., rifampin): accelerate lamotrigine metabolism.

Moderate Interactions (Monitor Closely): - Serotonergic agents: may increase risk of serotonin syndrome. - NSAIDs: can raise the incidence of skin reactions. - Alcohol: may enhance central nervous system depression. - Other antiepileptics: may require therapeutic drug monitoring.